Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

This study has been terminated.
Information provided by:
Health Innovations, Frontier Research Institute Identifier:
First received: November 29, 2010
Last updated: February 17, 2011
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)